For a company with such a wide international footprint, Oyo-parent Prism's choice of India over U.S. exchanges is symbolic ...

PRISM BioLab, Co. Ltd. ('PRISM') and Talus Bioscience, Inc. ('Talus Bio') announced today that they entered into a collaboration to discover novel Inhibitors of transcription factor (TF) and ...

Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. (“PRISM”) to accelerate the discovery and ...

Like her, there was learning aplenty for students from different Calcutta schools at the 14th edition of Exe.bit, a three-day ...

Arcus ends its Phase 3 STAR-221 trial after a futility review and shifts R&D toward casdatifan, supported by strong early RCC ...

As ACA tax credits near expiration under Trump’s “Big Beautiful Bill,” Pennsylvania health care consumers face higher ...

Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

Watch closely and you will see why Kobbie Mainoo might infuriate his Manchester United manager. United dominate the Mailbox ...

Demand for student visas surged after Myanmar’s coup. Now, Trump has shut a door students spent years trying to open.

A handful of famous people currently teach at the University of Michigan, and their salaries are just as public as other employees. These celebrities include Grammy winners and acclaimed writers.

Physik Instrumente (PI), the Karlsruhe, Germany, company that is well known across the optics and photonics sector for its high-precision motion and positioning equipment, is to become part of the ...

The Phase 3 STAR-221 study evaluating a domvanalimab-based combination in upper gastrointestinal cancers will be discontinued due to futilityArcus is continuing to expand its development program for ...